Evidence map›Paper›PMID 35648202›Full record

ArticlePsychopharmacology2022

Correction to: The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age‑matched controls.

W Lawn, N Fernandez-Vinson, C Mokrysz, G Hogg, R Lees, K Trinci, K Petrilli, A Borissova, S Ofori, S Waters and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Psychopharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

W LawnClinical Psychopharmacology Unit, University College London, London, UK. will.lawn@kcl.ac.uk.
N Fernandez-VinsonClinical Psychopharmacology Unit, University College London, London, UK.
C MokryszClinical Psychopharmacology Unit, University College London, London, UK.
G HoggClinical Psychopharmacology Unit, University College London, London, UK.
R LeesAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
K TrinciClinical Psychopharmacology Unit, University College London, London, UK.
K PetrilliAddiction and Mental Health Group (AIM), Department of Psychology, University of Bath, Bath, UK.
A BorissovaDepartment of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
S OforiClinical Psychopharmacology Unit, University College London, London, UK.
S WatersDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK.
P MichórSchool of Life Sciences, University of Warwick, Coventry, UK.
M B WallClinical Psychopharmacology Unit, University College London, London, UK.
T P FreemanClinical Psychopharmacology Unit, University College London, London, UK.
H V CurranClinical Psychopharmacology Unit, University College London, London, UK.

Funding

Medical Research Council MR/P012728/1
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35648202
PMCPMC9205827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.